N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor

Details for Australian Patent Application No. 2003291282 (hide)

Owner Prolx Pharmaceuticals Corporation Arizona Board of Regents, acting on behalf of the University of Arizona

Inventors Kirkpatrick, Lynn; Welsh, Sarah J.; Powis, Garth

Agent Pizzeys

Pub. Number AU-B-2003291282

PCT Number PCT/US2003/0352

PCT Pub. Number WO2004/043359

Priority 10/288,888 06.11.02 US

Filing date 3 November 2003

Wipo publication date 3 June 2004

Acceptance publication date 11 November 2010

International Classifications

C07F 9/6584 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/195 (2006.01)

A61K 31/66 (2006.01) - Phosphorus compounds

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 10/288,888 06.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2003291282

11 November 2010 Application Accepted

  Published as AU-B-2003291282

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003291283-DOUGH AND METHOD FOR PREPARING LEAVENED FOOD PRODUCT

2003291281-CYTOGENETIC ABNORMALITIES THAT ARE PREDICTIVE OF RESPONSE TO THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA